3-((4-(2-Butyl-1-(4-(4-chlorophenoxy)phenyl)-1H-imidazole-4-yl)piperidin-1-yl)ethyl)-1H-indole-5-carbonitrile

ID: ALA5172714

Chembl Id: CHEMBL5172714

PubChem CID: 163216021

Max Phase: Preclinical

Molecular Formula: C35H36ClN5O

Molecular Weight: 578.16

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCc1nc(C2CCN(CCc3c[nH]c4ccc(C#N)cc34)CC2)cn1-c1ccc(Oc2ccc(Cl)cc2)cc1

Standard InChI:  InChI=1S/C35H36ClN5O/c1-2-3-4-35-39-34(24-41(35)29-8-12-31(13-9-29)42-30-10-6-28(36)7-11-30)26-15-18-40(19-16-26)20-17-27-23-38-33-14-5-25(22-37)21-32(27)33/h5-14,21,23-24,26,38H,2-4,15-20H2,1H3

Standard InChI Key:  NSTCHFNFLIONCS-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5172714

    ---

Associated Targets(Human)

AGER Tchem Advanced glycosylation end product-specific receptor (291 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 578.16Molecular Weight (Monoisotopic): 577.2608AlogP: 8.44#Rotatable Bonds: 10
Polar Surface Area: 69.87Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 9.31CX LogP: 8.14CX LogD: 6.22
Aromatic Rings: 5Heavy Atoms: 42QED Weighted: 0.18Np Likeness Score: -1.18

References

1. Zhang C, Wang L, Xu Y, Huang Y, Huang J, Zhu J, Wang W, Li W, Sun A, Li X, Zhang H, Li J..  (2022)  Discovery of novel dual RAGE/SERT inhibitors for the potential treatment of the comorbidity of Alzheimer's disease and depression.,  236  [PMID:35430560] [10.1016/j.ejmech.2022.114347]

Source